Search
                    Obsessive-Compulsive Disorder Clinical Trials
A listing of 33  Obsessive-Compulsive Disorder  clinical trials  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 12 of 33
        
                There are currently 33 active clinical trials seeking participants for Obsessive-Compulsive Disorder research studies. The states with the highest number of trials for Obsessive-Compulsive Disorder participants are California, Florida, New York and Massachusetts.
            
                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
                                
            
            
        Recruiting
                            
            
                The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                08/12/2025
            
            Locations: Yale OCD Research Clinic - CMHC/CNRU, 34 Park ST, New Haven, Connecticut         
        
        
            Conditions: Obsessive-Compulsive Disorder
        
            
        
    
                
                                    CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to examine whether youth with OCD who benefit from CBT augmentation to SRI can discontinue their medication without relapse over 24 weeks.             
        
        
    Gender:
                ALL
            Ages:
                Between 7 years and 17 years
            Trial Updated:
                07/18/2025
            
            Locations: Baylor College of Medicine, Houston, Texas         
        
        
            Conditions: Cognitive Behavioral Therapy, Obsessive-Compulsive Disorder, Obsessive-Compulsive Disorder in Children, Obsessive-Compulsive Disorder in Adolescence
        
            
        
    
                
                                    Effects of Repeated Psilocybin Dosing in OCD
                                
            
            
        Recruiting
                            
            
                This study aims to investigate the effects of repeated dosing of oral psilocybin on obsessive-compulsive disorder (OCD) symptomatology in a randomized, waitlist-controlled design with blinded independent ratings, and assess psychological mechanisms that may mediate psilocybin's therapeutic effects on OCD.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                07/09/2025
            
            Locations: Yale OCD Research Clinic (40 Temple St, 4th Floor), New Haven, Connecticut         
        
        
            Conditions: Obsessive-Compulsive Disorder
        
            
        
    
                
                                    Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation
                                
            
            
        Recruiting
                            
            
                This is a pilot study to examine the tolerability, safety and early efficacy of two forms of transcranial magnetic stimulation (TMS) for treating adolescents with Obsessive Compulsive Disorder (OCD) who have experienced limited improvements with usual treatments for OCD in adolescents.
The project's primary goal is to examine whether adolescents can complete 3 consecutive weeks of TMS administered 5 days per week, and to describe the type of and how common individual side effects with TMS occur...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 13 years and 17 years
            Trial Updated:
                07/03/2025
            
            Locations: University of California, San Francisco, San Francisco, California         
        
        
            Conditions: Obsessive-Compulsive Disorder
        
            
        
    
                
                                    CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
                                
            
            
        Recruiting
                            
            
                Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a novel biomarker based on a CO2 challenge, thus addressing the central question "can this easy-to-administer assay aid clinicians in deciding whether or not to initiate exposure-based therapy?"             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 70 years
            Trial Updated:
                06/18/2025
            
            Locations: Boston University, Boston, Massachusetts  +1 locations         
        
        
            Conditions: Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder
        
            
        
    
                
                                    Transcranial Direct Current Stimulation Potentiation of Fear Extinction in OCD
                                
            
            
        Recruiting
                            
            
                The investigators want to learn more about how human beings learn not to fear and the impact of changing the fear network in the brain using transcranial Direct Current Stimulation (tDCS) in individuals with obsessive compulsive disorder (OCD). The investigators hope this study will help us understand how future treatments can help patients with OCD better control unwanted fear.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 60 years
            Trial Updated:
                06/10/2025
            
            Locations: Massachusetts General Hospital, Boston, Massachusetts         
        
        
            Conditions: Obsessive-Compulsive Disorder
        
            
        
    
                
                                    Theta Burst Stimulation Plus Habit Override Training for Compulsive Behaviors
                                
            
            
        Recruiting
                            
            
                This project seeks to identify causal neural mechanisms underlying unwanted, repetitive behaviors (compulsions). Using non-invasive brain stimulation coupled with practice in a computer task, we will modulate activity in a target brain region and measure effects on compulsive behaviors and related measures. This work could ultimately lead to the ability to treat compulsions more effectively by targeting the regions of the brain that can help or hinder attempts to overcome compulsions.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 60 years
            Trial Updated:
                06/09/2025
            
            Locations: Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania         
        
        
            Conditions: Compulsive Behavior, Obsessive-Compulsive Disorder
        
            
        
    
                
                                    A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
                                
            
            
        Recruiting
                            
            
                The primary aim of the present study is to examine the efficacy and safety of tolcapone in adults with moderate to severe OCD.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                06/02/2025
            
            Locations: University of Chicago Medical Center, Chicago, Illinois         
        
        
            Conditions: Obsessive-Compulsive Disorder, OCD
        
            
        
    
                
                                    Using Personalized Assessments in the Treatment of Childhood OCD
                                
            
            
        Recruiting
                            
            
                The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are feasible and acceptable for youth and parents. The investigators will also examine whether personalized cognitive-behavioral therapy (CBT) that is informed by personalized OCD assessments yields better clinical outcomes when compared to standard CBT for youth with OCD             
        
        
    Gender:
                ALL
            Ages:
                Between 8 years and 17 years
            Trial Updated:
                05/14/2025
            
            Locations: Johns Hopkins University School of Medicine, Baltimore, Maryland         
        
        
            Conditions: Obsessive-Compulsive Disorder
        
            
        
    
                
                                    Effects of Psilocybin in Obsessive Compulsive Disorder
                                
            
            
        Recruiting
                            
            
                This study will test the feasibility, safety, and evidence for efficacy of psilocybin administration in participants with obsessive compulsive disorder (OCD). This will serve as a preliminary proof of concept study for future larger studies aimed to investigate the utility, cognitive mechanisms, and neural correlates of this intervention.             
        
        
    Gender:
                ALL
            Ages:
                Between 21 years and 70 years
            Trial Updated:
                05/12/2025
            
            Locations: Johns Hopkins University School of Medicine, Baltimore, Maryland         
        
        
            Conditions: Obsessive-Compulsive Disorder
        
            
        
    
                
                                    Interpretation Bias as a Mechanism of Treatment Response in OCD
                                
            
            
        Recruiting
                            
            
                This study will conduct a randomized controlled trial of Cognitive Bias Modification for Interpretation (CBM-I) as an augmentation to treatment as usual for obsessive compulsive disorder (OCD). CBM-I is a digital intervention designed to directly manipulate interpretation bias through repeated practice on a training task, thereby inducing cognitive changes in a relatively automatic or implicit manner. Specifically, this study will examine the feasibility, acceptability, and clinical outcomes ass...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/05/2025
            
            Locations: McLean Hospital, Belmont, Massachusetts         
        
        
            Conditions: Obsessive-Compulsive Disorder
        
            
        
    
                
                                    Personalized DBS for OCD Guided by Stereoencephalography Mapping
                                
            
            
        Recruiting
                            
            
                This is a double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and optimization of stimulation parameters. Stage 2 will consist of 4-lead DBS surgery with bilateral IPGs and further optimization of stimulation parameters. Stage 3 will be randomized, crossover treatment, followed by open label trea...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 22 years and 75 years
            Trial Updated:
                04/18/2025
            
            Locations: University of California, San Francisco, San Francisco, California         
        
        
            Conditions: Obsessive-Compulsive Disorder, OCD
        
            
        
    1 - 12 of 33
            